In summary, the present study uncovered the pathological significance of menin/SETD2-mediated H3K36me3 reprogramming in liver fibrosis, providing new insights into the reversible intervention of liver fibrosis. The gene discussed is SETD2; the disease is Hepatic fibrosis.